Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Journal of Medical Case Reports
|
March 26, 2014
Erlotinib-induced complete response in a patient with epidermal growth factor receptor wild-type lung adenocarcinoma after chemotherapy failure: a case report
Maria Giuseppa Vitale, Ferdinando Riccardi, Carmela Mocerino, et al.
Journal of Anatomy
|
February 22, 2013
Expression of orexin A and its receptor 1 in the human prostate
Salvatore Valiante, Giovanna Liguori, Simona Tafuri, et al.
World Journal of Surgical Oncology
|
February 9, 2010
Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer
Ferdinando Riccardi, Giuseppe Di Lorenzo, Carlo Buonerba, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 27, 2019
Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma
Francesco Morra, Francesco Merolla, Debora D'Abbiero, et al.
Biochemical and Biophysical Research Communications
|
July 30, 2015
Expression and potential role of the peptide orexin-A in prostate cancer
Salvatore Valiante, Giovanna Liguori, Simona Tafuri, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 4, 2016
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs
Umberto Malapelle, Francesco Morra, Gennaro Ilardi, et al.
Frontiers in Endocrinology
|
June 2, 2012
Partitioning of bronchopulmonary carcinoids in two different prognostic categories by ki-67 score
Franco Grimaldi, Daniele Muser, Carlo Alberto Beltrami, et al.
BMJ (Clinical Research Ed.)
|
March 29, 2020
Italian doctors call for protecting healthcare workers and boosting community surveillance during covid-19 outbreak
Filippo Anelli, Giovanni Leoni, Roberto Monaco, et al.
Oncotarget
|
April 18, 2015
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC
Francesco Morra, Chiara Luise, Francesco Merolla, et al.
Journal of Translational Medicine
|
May 30, 2024
Immune cell infiltration and inflammatory landscape in primary brain tumours
Amalia Luce, Marianna Abate, Giosuè Scognamiglio, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Journal of Medical Case Reports
|
March 26, 2014
Erlotinib-induced complete response in a patient with epidermal growth factor receptor wild-type lung adenocarcinoma after chemotherapy failure: a case report
Maria Giuseppa Vitale, Ferdinando Riccardi, Carmela Mocerino, et al.
Journal of Anatomy
|
February 22, 2013
Expression of orexin A and its receptor 1 in the human prostate
Salvatore Valiante, Giovanna Liguori, Simona Tafuri, et al.
World Journal of Surgical Oncology
|
February 9, 2010
Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer
Ferdinando Riccardi, Giuseppe Di Lorenzo, Carlo Buonerba, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 27, 2019
Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma
Francesco Morra, Francesco Merolla, Debora D'Abbiero, et al.
Biochemical and Biophysical Research Communications
|
July 30, 2015
Expression and potential role of the peptide orexin-A in prostate cancer
Salvatore Valiante, Giovanna Liguori, Simona Tafuri, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 4, 2016
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs
Umberto Malapelle, Francesco Morra, Gennaro Ilardi, et al.
Frontiers in Endocrinology
|
June 2, 2012
Partitioning of bronchopulmonary carcinoids in two different prognostic categories by ki-67 score
Franco Grimaldi, Daniele Muser, Carlo Alberto Beltrami, et al.
BMJ (Clinical Research Ed.)
|
March 29, 2020
Italian doctors call for protecting healthcare workers and boosting community surveillance during covid-19 outbreak
Filippo Anelli, Giovanni Leoni, Roberto Monaco, et al.
Oncotarget
|
April 18, 2015
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC
Francesco Morra, Chiara Luise, Francesco Merolla, et al.
Journal of Translational Medicine
|
May 30, 2024
Immune cell infiltration and inflammatory landscape in primary brain tumours
Amalia Luce, Marianna Abate, Giosuè Scognamiglio, et al.
Page
of 3